[速報]HLB"リボセラニブ、腺様嚢胞癌FDA承認」
[速报] HLB " Rivoceranib, 腺阳囊性癌 FDA 认证"
[Срочные новости] HLB - "Рибоцераниб, одобрен FDA для рака желчного пузыря"
[속보] HLB "리보세라닙, 선양낭성암 FDA 승인” [More News]
The message left by this news reporter
| There are 0 comments in total |